BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22820159)

  • 1. Identifying leukemia stem cells--is it feasible and does it matter?
    Lutz C; Hoang VT; Buss E; Ho AD
    Cancer Lett; 2013 Sep; 338(1):10-4. PubMed ID: 22820159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukemia stem cells.
    Buss EC; Ho AD
    Int J Cancer; 2011 Nov; 129(10):2328-36. PubMed ID: 21796620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of leukemia stem cells in acute myeloid leukemia and their clinical relevance.
    Hoang VT; Zepeda-Moreno A; Ho AD
    Biotechnol J; 2012 Jun; 7(6):779-88. PubMed ID: 22588704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients.
    Hoang VT; Buss EC; Wang W; Hoffmann I; Raffel S; Zepeda-Moreno A; Baran N; Wuchter P; Eckstein V; Trumpp A; Jauch A; Ho AD; Lutz C
    Int J Cancer; 2015 Aug; 137(3):525-36. PubMed ID: 25545165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD/SCID engrafting potential.
    Cheung AM; Wan TS; Leung JC; Chan LY; Huang H; Kwong YL; Liang R; Leung AY
    Leukemia; 2007 Jul; 21(7):1423-30. PubMed ID: 17476279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9.
    Krivtsov AV; Twomey D; Feng Z; Stubbs MC; Wang Y; Faber J; Levine JE; Wang J; Hahn WC; Gilliland DG; Golub TR; Armstrong SA
    Nature; 2006 Aug; 442(7104):818-22. PubMed ID: 16862118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute myelogenous leukemia stem cells: from Bench to Bedside.
    Felipe Rico J; Hassane DC; Guzman ML
    Cancer Lett; 2013 Sep; 338(1):4-9. PubMed ID: 22713929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective elimination of leukemia stem cells: hitting a moving target.
    Crews LA; Jamieson CH
    Cancer Lett; 2013 Sep; 338(1):15-22. PubMed ID: 22906415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms controlling pathogenesis and survival of leukemic stem cells.
    Jordan CT; Guzman ML
    Oncogene; 2004 Sep; 23(43):7178-87. PubMed ID: 15378078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and separation of normal hematopoietic stem cells and leukemia stem cells from patients with acute myeloid leukemia.
    Hoang VT; Hoffmann I; Borowski K; Zepeda-Moreno A; Ran D; Buss EC; Wuchter P; Eckstein V; Ho AD
    Methods Mol Biol; 2013; 1035():217-30. PubMed ID: 23959995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldehyde dehydrogenase activity among primary leukemia cells is associated with stem cell features and correlates with adverse clinical outcomes.
    Ran D; Schubert M; Pietsch L; Taubert I; Wuchter P; Eckstein V; Bruckner T; Zoeller M; Ho AD
    Exp Hematol; 2009 Dec; 37(12):1423-34. PubMed ID: 19819294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiles of AML derived stem cells; similarity to hematopoietic stem cells.
    Gal H; Amariglio N; Trakhtenbrot L; Jacob-Hirsh J; Margalit O; Avigdor A; Nagler A; Tavor S; Ein-Dor L; Lapidot T; Domany E; Rechavi G; Givol D
    Leukemia; 2006 Dec; 20(12):2147-54. PubMed ID: 17039238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity.
    Hope KJ; Jin L; Dick JE
    Nat Immunol; 2004 Jul; 5(7):738-43. PubMed ID: 15170211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.
    Moore MA; Dorn DC; Schuringa JJ; Chung KY; Morrone G
    Exp Hematol; 2007 Apr; 35(4 Suppl 1):105-16. PubMed ID: 17379095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal and leukaemic stem cells.
    Bonnet D
    Br J Haematol; 2005 Aug; 130(4):469-79. PubMed ID: 16098060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe hypoxia defines heterogeneity and selects highly immature progenitors within clonal erythroleukemia cells.
    Giuntoli S; Rovida E; Gozzini A; Barbetti V; Cipolleschi MG; Olivotto M; Dello Sbarba P
    Stem Cells; 2007 May; 25(5):1119-25. PubMed ID: 17255519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemia stem cells.
    Lane SW; Gilliland DG
    Semin Cancer Biol; 2010 Apr; 20(2):71-6. PubMed ID: 20026405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chronic myeloid leukemia stem cell.
    Nicholson E; Holyoake T
    Clin Lymphoma Myeloma; 2009; 9 Suppl 4():S376-81. PubMed ID: 20007106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute myeloid leukemia stem cells.
    Dick JE
    Ann N Y Acad Sci; 2005 Jun; 1044():1-5. PubMed ID: 15958691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unique molecular and cellular features of acute myelogenous leukemia stem cells.
    Jordan CT
    Leukemia; 2002 Apr; 16(4):559-62. PubMed ID: 11960332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.